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Aims Atrial fibrillation (AF) is the most common type of cardiac arrhythmias, whose incidence is likely to increase with the ag-
ing of the population. It is considered a progressive condition, frequently observed as a complication of other cardiovas-
cular disorders. However, recent genetic studies revealed the presence of several mutations and variants linked to AF,
findings that define AF as a multifactorial disease. Due to the complex genetics and paucity of models, molecular mecha-
nisms underlying the initiation of AF are still poorly understood. Here we investigate the pathophysiological mechanisms
of a familial form of AF, with particular attention to the identification of putative triggering cellular mechanisms, using
patient’s derived cardiomyocytes (CMs) differentiated from induced pluripotent stem cells (iPSCs).
....................................................................................................................................................................................................
Methods
and results
Here we report the clinical case of three siblings with untreatable persistent AF whose whole-exome sequence analysis
revealed several mutated genes. To understand the pathophysiology of this multifactorial form of AF we generated three iPSC
clones from two of these patients and differentiated these cells towards the cardiac lineage. Electrophysiological characterization
of patient-derived CMs (AF-CMs) revealed that they have higher beating rates compared to control (CTRL)-CMs. The analysis
showed an increased contribution of the If and ICaL currents. No differences were observed in the repolarizing current IKr and
in the sarcoplasmic reticulum calcium handling. Paced AF-CMs presented significantly prolonged action potentials and, under
stressful conditions, generated both delayed after-depolarizations of bigger amplitude and more ectopic beats than CTRL cells.
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Conclusions Our results demonstrate that the common genetic background of the patients induces functional alterations of If
and ICaL currents leading to a cardiac substrate more prone to develop arrhythmias under demanding conditions.
To our knowledge this is the first report that, using patient-derived CMs differentiated from iPSC, suggests a plausi-
ble cellular mechanism underlying this complex familial form of AF.
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Graphical Abstract
1. Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring
in 1–2% of the general population, but with a greater incidence in the el-
derly. In this type of arrhythmia, ectopic activity originating outside the si-
noatrial node, gives rise to a disorganized electrical activation due to a
cellular substrate susceptible to re-entrant circuits. While AF is com-
monly associated with structural heart diseases and is a major cause of
cardiovascular morbidity and mortality in the elderly, it sometimes devel-
ops in a subset of patients younger than 60, with no evidence of associ-
ated cardiopulmonary or other diseases.
In recent years, evidence for inheritable forms of AF has grown. Beyond
the rare cases of monogenic forms of AF and linkage analysis that revealed
several genetic loci associated with AF,1 population-based studies have
shown that having first degree relatives with AF increases significantly the
probability to develop AF.2 Familial AF is likely associated with a complex
genetic background that predisposes to this arrhythmia and that may or
may not manifest itself depending on other non-genetic contributors.
Because of this genetic complexity, the molecular mechanisms underly-
ing the initiation of AF are still poorly understood and possibly involve a
complex interplay of various effectors.3 In addition, electrical disturbances
typical of AF cause the remodelling of the atria in a way that may sustain
the arrhythmic phenotype.4 This remodelling, in turn, makes it impossible
to discriminate between causes and effects of AF when analysing cardio-
myocytes (CMs) obtained from patient’s biopsies. Human induced pluripo-
tent stem cells-derived CMs (hiPSCs-CMs) may represent a valuable
model to study AF, since they carry the exact genetic background of the
patient but are free from the AF-dependent remodelling. hiPSC-CMs are
now recognized as a useful human model that recapitulates the functional
alterations underlying inherited arrhythmogenic diseases.5
2 P. Benzoni et al.
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In this work, we describe the first iPSC-derived model of human AF,
generated from two out of three siblings that developed a drug-resistant
form of AF at a relatively young age (<55 years). Using this model, we
compared molecular and electrophysiological properties of hiPSC-CMs
from AF patients (AF-CMs) and controls (CTRL-CMs), revealing altera-
tions in ionic currents that may represent one of the cellular mechanisms
that contribute to AF initiation.
2. Methods
2.1 AF patients
The three siblings were referred to Spedali Civili of Brescia (Italy), where
they were diagnosed for AF (for details on method see Supplementary
material online). Since all three patients were non-responsive to antiar-
rhythmic medication and failed previous transcatheter ablation, they
underwent surgical ablation as described in Supplementary material on-
line. A detailed clinical history of the patients is reported in the
Supplementary material online, Table S1.
2.2 Generation of hiPSCs and cardiac
differentiation
Blood and skin biopsies have been obtained from all three siblings fol-
lowing approved protocols by the Ethical Committee of Brescia (proto-
col number 1737) and a written consent obtained from the patients, in
agreement with the declaration of Helsinki. hiPSC were generated as
reported in Supplementary material online.
Cardiac differentiation of hiPSC was carried out either by embryoid
bodies (EBs), as previously described6 or by monolayer culture using the
PSC Cardiomyocyte Differentiation Kit (Thermo Fisher Scientific).
Differentiation in EBs was used for experiments on beating clusters to
record the spontaneous rate. All the other experiments were carried
out using the monolayer differentiation.
2.3 Electrophysiological and Ca2þ handling
analysis
Electrophysiological and Ca2þ handling experiments were performed on
dissociated hiPSC-CMs from at least three independent differentiation
experiments, using the patch-clamp technique in whole-cell configura-
tion. For protocols and solutions see Supplementary material online.
2.4 Statistics
Statistical analysis was carried out with Origin Pro 9, IBM SPSS Statistics
and R software. Groups were compared with one-way ANOVA fol-
lowed by pairwise comparison using Fisher’s test or by nested one-way
ANOVA with Holm P-value adjustment. Difference in events percentage
among groups was assessed by Fisher’s exact test, adjusting the P-value
with Bonferroni correction. P-value <0.05 defines statistical significance.
Data are presented as mean± SEM.
3. Results
3.1 Characteristics of patients: genetic
screening for mutations in AF-related
genes
We identified three siblings with untreatable AF (see exemplified elec-
trocardiogram in Supplementary material online, Figure S1 and clinical
characteristics in Supplementary material online, Table S1) who, due to
failure of pharmacological treatment, underwent surgical ablation.
Although they present other comorbidities (e.g. high body mass index
and hypertension) that may importantly contribute to the poor control
of the pathology, the familiarity, and their young age of onset of AF,
strongly support a genetic basis for this form of arrhythmia.
In an attempt to identify potential AF-related mutations within the
family we performed a whole exome sequencing in which data obtained
from the three siblings (dubbed AF1, AF2, and AF3) were compared
with 6000 human reference genomes (GRC37/hg19). We identified
more than one hundred variants common only to the three siblings (see
Supplementary material online, Table S2). Only few of these variants
were in genes previously associated with AF (ZFHX3) and expressed
also in the heart (PDE4DIP, CNN2, RYR3, NEFM, FLNC, and MYLK).
Because of the complex genetic background of the family and the lack of
unquestionably healthy relatives, we decided to address the molecular
basis of this form of AF from a functional point of view.
3.2 Generation of hiPSC clones
To highlight possible common functional cardiac alterations in these
patients, we generated patient-derived iPSCs and differentiated them
into CMs. The reprogramming procedure was effective for fibroblasts
obtained from AF1 and AF2, which allowed the generation of three
hiPSC clones (AF1 n= 2; AF2 n= 1).
In the absence of unquestionably healthy parental or isogenic controls,
AF clones were compared with at least three of four different unrelated
control clones: one derived from dermal fibroblasts of an age-matched
healthy woman7 (CTRL1); one derived from epidermal keratinocytes8
(CTRL2); one derived from dermal fibroblasts of a young male (CTRL3
shown in Figure 1B and C); and the last one from blood cells of a 62-year-
old male not affected by AF or other cardiac pathologies (CTRL4).
The clones obtained from AF1 and AF2 were tested for the expres-
sion of both exogenous (t) and endogenous (e) pluripotency genes
OCT4, SOX2, NANOG, and REX1 by qPCR (Figure 1A) or by immunocyto-
chemistry (Figure 1B). They were further screened for morphological
properties typical of pluripotent colonies, such as sharp borders, the
absence of a central dark area, and the expression of alkaline phospha-
tase (Figure 1B). The maintenance of a normal karyotype was also verified
by quinacrine staining of metaphase plates (Figure 1B). Finally, the capac-
ity to differentiate towards the three germ layers was confirmed by
immunostaining with specific antibodies recognizing the ectodermal pro-
tein Nestin or Class III beta-Tubulin (TUJ1), the mesodermal protein
smooth muscle actin, and the endodermal protein alpha fetoprotein
(Figure 1C).
3.3 AF and CTRL hiPSCs differentiate into
CMs with similar efficiency
For the experiments evaluating beating rate of clusters of hiPSC-CMs,
clones were differentiated towards the cardiac lineage using a previously
published procedure that involves spontaneous formation of EBs.6 For
all remaining experiments, we switched to a commercially available car-
diac differentiation kit that ensured a higher yield of CMs.
Besides the appearance of beating areas, CMs in AF and CTRL groups
were evaluated for the expression of the cardiac troponin gene
(TNNT2) and the atrial gene sarcolipin (SLN) at day 30 of differentiation,
by qPCR. The plots in Figure 2A (top panels) show that the levels of
TNNT2 and SLN were similar in all groups.
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Figure 1 Pluripotency characterization. (A) qPCR analysis of pluripotency gene expression in hiPSC using dermal fibroblasts as reference control equal to
1. tOCT4 and tSOX2 indicate the specific expression of transgenes, while eOCT4 and eSOX2 refer to expression of endogenous genes. Differences in gene ex-
pression levels were compared using one-way ANOVA followed by Fisher’s T-test. (B) Summary panels for AF1, AF2, and CTRL hiPSC lines, as indicated
(from left to right): bright-field images of primary fibroblasts, alkaline phosphatase activity in hiPSC-colonies, immunostaining of hiPSC for pluripotency
markers and karyotype. (C) Immunostaining of differentiated hiPSCs with antibodies recognizing ectodermal, mesodermal, and endodermal markers as
indicated.
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.We further investigated cardiac differentiation at the protein level by
assessing the expression of cardiac troponin I in cellular lysates using a
commercially available diagnostic kit (Figure 2B, left panel), finding no dif-
ferences among clones. CMs yield was evaluated by flow cytometry using
an anti-cardiac troponin T (cTNT) antibody. This analysis revealed that
around half of the population was composed by CMs (Figure 2B, right
panel). Again, no significant differences were found between AF and
CTRL clones. Top panels of Figure 2C show representative images of iso-
lated AF1-CMs, stained with cTNT and sarcomeric actin, displaying clear
sarcomeric structures. In differentiating monolayers (Figure 2C, bottom
panels), we evaluated the expression of the atrial myosin light chain
(MLC2a) typical of immature/atrial CMs; conversely, very poor
Figure 2 hiPSC-derived cardiomyocyte differentiation. (A) qPCR analysis of cardiac troponin T (TNNT2) and sarcolipin (SLN) expression at day 30 of dif-
ferentiation for AF1-, AF2-, and CTRL-CMs, as indicated. Undifferentiated hiPSC were used as negative control. (B) Quantification of cardiac troponin I (mg)
on total protein content (TP, mg) of AF1 (2.9± 0.46; n= 3), AF2 (2.4± 1.37; n= 3), CTRL (2.36 ± 1.08; n= 6), and hiPSCs (0.002± 0.01; n= 2) (left).
Representative flow cytometry analysis on hiPSC-differentiated cells using an anti-cardiac troponin T antibody: AF1 (45.1 ± 11 n= 3), AF2 (55.2 ± 19 n= 3),
CTRL (52 ± 12 n= 6) (right). (C) Representative images of isolated AF1-CM and AF1-differentiated monolayers stained for cardiac troponin T (cTNT), sar-
comeric actin (a-SARC), atrial (MLC2a), and ventricular (MLC2v) myosin light chains; nuclei were counterstained with DAPI. (D) Ratios between the qPCR
expression levels of heavy (left) and light (right) chain isoforms of myosin. Human atria (hA) and ventricles (hV) were used as positive and negative controls,
respectively. Differences in gene expression and protein quantification were assessed by one-way ANOVA followed by Fisher’s T-test.
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staining was obtained using anti-ventricular light chain (MLC2v)
antibodies.
To better characterize the maturation stage reached at 30 days and
the subtype of CM obtained, we measured the expression of the genes
corresponding to the alfa (atrial) and beta (ventricular) myosin heavy
chain (MYH6 and MYH7, respectively) and atrial and ventricular light
chains (MYL7 and MYL2, respectively) by qPCR. Figure 2D shows
that the mean MYH6/MYH7 ratio values were similar among hiPSC-CMs
and comparable to values found in human adult atrium but not
human ventricles. These data together with SLN expression, further sug-
gest an immature/atrial rather than a ventricular phenotype for hiPSC-
CMs.
Taken together these data confirm the reproducibility of the differen-
tiating procedure among different groups and indicate that no significant
differences in CM differentiation were found between AF and CTRL
hiPSC lines.
3.4 hiPSC-CMs from AF patients display a
higher beating rate than CTRL
In order to investigate the molecular mechanisms contributing to AF in
our patients, we compared the electrophysiological properties of AF-
and CTRL-CMs. Because data obtained from CMs of different CTRL
clones were similar (Supplementary material online, Figure S2 and Tables
S3–S5), they were pooled together.
Representative action potential (AP) traces, recorded from spontane-
ously beating hiPSC-CM aggregates derived from AF1, AF2, and CTRL
lines are shown in Figure 3A; even if the intra-clone variability was rela-
tively large, on average aggregates derived from the two patients were
beating at significantly higher rates than those derived from control lines
(Figure 3B; see also Supplementary material online, Movies S1 and S2).
No significant differences in maximum diastolic potential, amplitude,
and rate-corrected duration9 were observed (Supplementary material
online, Table S3). To test if the higher rate could result from elevated
concentrations of intracellular cyclic AMP (cAMP), cells were challenged
with a saturating concentration of the b-adrenergic agonist isoprotere-
nol (Iso 1mM). Panels of Figure 3C show representative time courses of
spontaneous action potential rate in control, during superfusion of iso-
proterenol and after washout. The mean graph of Figure 3D shows that
the fractional rate acceleration caused by isoproterenol was similar in all
groups, suggesting that the higher basal beating rate does not depend on
the modulatory pathway but likely derives from an intrinsic modification
of the pacemaking mechanisms. On the other hand, we evaluated the ef-
fect of superfusion of the bradycardic agent ivabradine (3mM). Panels in
Figure 3E show representative time courses of spontaneous action po-
tential rate in control, during ivabradine perfusion and after washout.
The mean graph of Figure 3F shows that the fractional rate reduction
caused by ivabradine was significantly higher in AF groups, abolishing the
rate difference. These data suggest a higher than normal contribution of
If to the pacemaker activity of beating AF-CMs.
3.5 hiPSC-CMs from AF patients show a
gain of function of f-channels
Since the If current is a major contributor to control beating rate,
10,11 we
measured the pacemaker If current in isolated AF-CMs at day 15 and day
30 of differentiation, while controlling at the same time the expression of
the HCN genes responsible for this current (Figure 4). Expression analy-
sis revealed that HCN1, HCN2, and HCN3 isoforms were expressed at
comparable low levels in all groups while HCN4, the most abundant
isoform, was significantly more expressed in CTRL than in AF1- and
AF2-CMs (Figure 4A).
Such increase in HCN4 expression could not be confirmed by immu-
nofluorescence analysis; representative confocal images shown in Figure
4B display similar HCN4 expression in CMs derived from the various
hiPSC lines.
Functional data instead demonstrated a significant gain of function of f-
channels in AF-CMs compared to CTRL cells, as shown by the represen-
tative families of If traces recorded from 30-day-old hiPSC-CMs (Figure
4C) and by the mean current density-voltage relations for AF1-, AF2-,
and CTRL-CMs (Figure 4D, top). Interestingly, besides having higher den-
sity, f-channels of AF-CMs also activated at significantly more positive
potentials than in CTRL-derived cells, as apparent from the mean activa-
tion curves shown in Figure 4D (bottom). It is noteworthy that at an ear-
lier stage of differentiation (between day 15 and 20), while the current
density does not differ among groups, f-channels activation is already
shifted by 7 and 10 mV towards more positive potentials in AF1- and
AF2-CMs, respectively, compared to CTRL (see Supplementary material
online, Figure S3). Superfusion with isoproterenol (100 nM), which is
known to cause a cAMP-dependent positive shift of If activation curve,
12
had similar effects in all groups (shift: AF1 = 4.0± 0.5 mV, n= 15;
AF2 = 4.1 ± 0.5 mV, n= 21; CTRL = 5.0 ± 0.7 mV, n= 9), indicating that
the more positive activation depends on changes in the intrinsic proper-
ties of the channel rather than a functional modulation due to alteration
in cytosolic cAMP homeostasis. Since a mis-interaction of HCN channels
with caveolin-3 (CAV3) may cause both a shift of their voltage depen-
dence and decrease in membrane expression,13,14 we evaluated if the
more positive activation in AF-CMs could be due to either a decreased
expression of CAV3 or a mis-localization of the channel and CAV3. We
found that CAV3 was equally expressed in AF- and CTRL-CMs
and HCN4 co-localized with CAV3 (Supplementary material online,
Figure S4).
3.6 AF-CMs display an increase in the L-
type calcium current with a preserved
calcium handling
Antiarrhythmic drugs aimed at controlling heart rhythm often target cal-
cium currents and in particular L-type calcium currents. We thus evalu-
ated the expression levels and functional properties of calcium channels.
qPCR analysis revealed that CACNA1C and CACNA1D genes, respon-
sible for the ICaL current, were similarly expressed in AF- and CTRL-
CMs with CACNA1C as the prevalent isoform (Figure 5A).
Electrophysiological analysis revealed instead that AF-derived cells show
a significantly larger nifedipine-sensitive ICaL current than CTRL-CMs as
shown by representative traces in Figure 5B and by the mean current
density-voltage relations plotted in Figure 5C (top). All samples had simi-
lar activation and inactivation curves (Figure 5C, bottom).
Notably, the difference in ICaL density was already detectable at an early
stage of differentiation (see Supplementary material online, Figure S3). We
did not detect the expression of CACNA1G gene (Figure 5A) and indeed
we could never record a T-type calcium current (data not shown).
To verify whether ICaL enhancement in AF-CMs might alter the ex-
citation-contraction coupling mechanism, intracellular Ca2þ handling
was evaluated. In order to analyse only the primary effects on the in-
tracellular Ca2þ handling, cells were voltage-clamped and stimulated
at 1 Hz and diastolic calcium (Cadiast), Ca
2þ transient (CaT) ampli-
tude, and sarcoplasmic reticulum (SR) Ca2þcontent (CaSR) mea-
sured. In Figure 5D left, representative traces are shown together
6 P. Benzoni et al.
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..with the protocol. The analysis revealed that Cadiast was similar in all
groups, while AF1-CMs showed an increased CaT amplitude and an
increase in CaSR, compared to CTRL-CMs and AF2-CMs. AF2-CMs
values were similar to those of CTRL-CMs. However, fractional re-
lease (FR) did not change among groups, suggesting a preserved SR
stability in AF as in CTRL cells under resting condition (Figure 5D,
right). The Ca2þ parameters for the three separate CTRL lines can
be found in Supplementary material online, Table S5. In agreement
with these data, Western blot analyses on SERCA2 and phospholam-
ban did not reveal any difference (Supplementary material online,
Figure S5).
3.7 AF-CMs show longer action potential
duration without changes in repolarizing
currents
Once isolated, the great majority of hiPSC-CMs were quiescent but
when stimulated (at 1 Hz) they fired action potentials. In Figure 6, the his-
tograms of action potential duration (APD)90 obtained from AF1-, AF2-,
and CTRL-CMs show that, despite the large variability of data, intrinsic
to this cell model, AF-CMs have a wider distribution of APD (Figure 6A)
with action potentials lasting as much as 300 ms, while none of the action
potentials recorded from CTRL-CMs lasted more than 200 ms. In Figure
Figure 3 hiPSC-CMs from AF patients show increased spontaneous firing rate and similar response to b-adrenergic stimulation compared to controls.
(A) Representative voltage traces of spontaneous firing recorded from hiPSC-CM clusters from AF1 and AF2 patients and CTRL as indicated. (B) Scatter
plot of the firing rate (open circles) and mean values (filled squares) of AF1 (0.88 ± 0.04 Hz, n/exp = 24/6), AF2 (0.99 ± 0.07 Hz, n/exp = 19/8), and CTRL
(0.72 ± 0.05 Hz, n/exp = 25/9) hiPSC-CMs. (C) Time course of the firing rate of representative hiPSC-CM clusters from AF1, AF2, and CTRL from top to bot-
tom, respectively; the black line indicates the time of isoproterenol perfusion. Insets show representative voltage traces before and during isoproterenol
stimulation. (D) Dot plot graph of the percentage increase in firing rate after isoproterenol stimulation. (AF1 100.6 ± 16.5%; n/exp = 8/3, AF2 87.0 ± 10.4%;
n/exp = 10/6, and CTRL 106.4 ± 9.4%; n/exp = 6/5). (E) Time course of the firing rate of representative hiPSC-CM clusters from AF1, AF2, and CTRL before,
during, and after ivabradine superfusion. Insets show representative voltage traces before and during ivabradine stimulation. (F) Dot plot of the percentage
decrease in firing rate after ivabradine superfusion (AF1 -35.2± 4.3%; n/exp = 8/3; AF2 -34.9 ± 6.8%; n/exp = 9/3; CTRL -16± 3.3%; n/exp = 8/3). Data were
compared using nested one-way ANOVA *P< 0.05.
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6B representative traces recorded from the three groups highlight the
prolongation of APD in AF-CMs.
On average patient-derived cells displayed significantly longer APD at
30, 50, and 90% of repolarization (see Table 1), in agreement with the
presence of a larger ICaL.
Because of this APD prolongation, we decided not to categorize
the CM population in nodal-, atrial-, or ventricular-like cells based on
the APD ratio. Indeed, the classifications based on either the APD90/
APD5015 or the APD30–40/APD70–80 ratios,16 revealed that 66.5
or 68.5% of CTRL-CMs seems to be atrial-like, while these percen-
tages were substantially lower for AF1-CMs (52.5–47.5%) and AF2-
CMs (48.7–41.0%). However, as apparent in the Supplementary ma-
terial online, Figure S6, most of the AF-derived CMs fall close to the
cut-off values separating atrial from ventricular cells. Since AF-CMs
Figure 4 If current is increased in AF-CMs. (A) qPCR analysis of HCN isoforms normalized to troponin T expression at day 30 of differentiation. (B)
Representative images of isolated AF1-, AF2-, and CTRL-CMs stained for HCN4 and cardiac troponin T (calibration bar = 10mm). (C) Representative traces
of If current density recorded at -35, -75, and -105 mV followed by a step at -125 mV from AF1-, AF2-, and CTRL-CMs. (D Top) Plot of mean If current den-
sity voltage relation from AF1-CMs (blue triangles), AF2-CMs (green inverted triangles), and CTRL-CMs (white circles); Peak current density (at -125mV):
AF1 = -7.17 ± 1.1*pA/pF, n/exp = 14/8; AF2 = -6.75± 0.72*pA/pF, n/exp = 13/3; CTRL = -3.45± 0.43 pA/pF, n/exp = 28/9. (Bottom) Mean activation curves
of If current from AF1-CMs, AF2-CMs, and CTRL-CMs (symbols as in top panel). V1/2 values: AF1 = -71.2± 1.6* mV, n/exp = 21/6; AF2 = -72.7± 1.3* mV, n/
exp = 15/4; CTRL = -81.5 ± 1.4 mV, n/exp = 28/9. Inverse slope factor values: AF1 = 8.4 ± 0.25, n= 21; AF2 = 7.5 ± 0.5, n= 15; CTRL = 9.5 ± 0.5, n= 28.
*P< 0.005. Data were compared using nested one-way ANOVA *P< 00.5.
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..show a larger ICaL and, as a consequence, a APD prolongation, a
certain number of atrial-like cells would indeed pass the threshold
and enter the ‘ventricular-like’ category even if they are not actually
ventricular cells. Therefore, in this specific case, a selection of
cells based on these criteria would obviously introduce a bias in the
results.
Of the main repolarizing currents, we were able to analyse the
delayed rectifier current IKr, whose density and kinetics did not differ be-
tween AF- and control-CMs (Supplementary material online, Figure S7).
Under our differentiation conditions IKs was absent while, in agreement
with the depolarized resting potential, IK1 was expressed at very low lev-
els (data not shown), as previously reported.17
Figure 5 L-type calcium current is increased in AF-CMs. (A) qPCR analysis of L-type calcium channel isoforms (1C, 1D) and T-type isoform (1G) expres-
sion normalized to troponin level at day 30 of differentiation. (B) Representative traces of ICaL current density recorded by 10 mV steps to the range of -40/
þ10 mV from AF1-, AF2-, and CTRL-CMs. (C Top) Plot of mean ICaL current density voltage relation from AF1-CMs (blue triangles), AF2-CMs (green
inverted triangles), and CTRL-CMs (white circles). Peak current density (at 10 mV): AF1 = -7.4 ± 0.6*pA/pF, n/exp = 34/6; AF2 = -6.9 ± 0.5*pA/pF, n/
exp = 30/8; CTRL = -4.7 ± 0.3 pA/pF, n/exp = 52/11. (Bottom) Mean activation and inactivation curves of ICaL current from AF1-CMs, AF2-CMs, and CTRL-
CMs (symbols as in top panel) V1/2 values of activation: AF1 = -6.6 ± 1.2 mV, n/exp = 29/6; AF2 = -6.8 ± 1.0 mV, n/exp = 31/8; CTRL = -7.4± 0.5 mV, n/
exp = 51/11. V1/2 values of inactivation: AF1 = -21.8 ± 0.7 mV, n/exp = 16/6; AF2 = -25.4 ± 0.8 mV, n/exp = 25/8; CTRL = -24.5 ± 0.5 mV, n/exp = 36/11. (D)
Left, examples of calcium transients recorded from AF1-, AF2-, and CTRL-CMs applying the protocol shown. Right, dot blot graphs of the Ca diast, CaT am-
plitude, CaSR, and FR data in the three groups, as indicated. For values see Supplementary material online, Table S5. Data were compared using nested one-
way ANOVA *P< 0.05 vs. CTRL; #P< 0.05 vs. AF2.
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Because of the difference in the L-type calcium current, we evaluated
the presence of calcium-dependent Kþ currents. Application of both
apamin (100 nM), a specific blocker of the SK3 channel and charybdo-
toxin (100 nM), a blocker of the BK channel, did not have any effect on
stimulated action potentials, thus suggesting a negligible expression of
these channels (data not shown).
3.8 AF-CMs display larger delayed-after-
depolarizations and an increased number
of ectopic beats under stressful conditions
Finally, we evaluated if the electrophysiological alterations found in
AF-CMs may be pro-arrhythmic by pacing both CTRL- and AF-CMs
at 0.5 Hz and superfusing them with isoproterenol (100 nM) and
E4031 (300 nM). This treatment, as expected, caused a significant
prolongation of the APD and eventually the development of
delayed-after-depolarizations (DADs) and/or triggered AP (Figure
7A). In Figure 7B, the proportion of CMs showing DADs, triggered
AP, or the APD prolongation only (no events) for AF1, AF2, and
CTRL-CMs is plotted. A significantly higher percentage of AF cells
displayed triggered AP than CTRL cells, under this stressful condi-
tion (Figure 7B).
Furthermore, even if the proportion of cells with DADs was not dif-
ferent among the three cell populations, on average, DADs from AF1
and AF2 cells had a higher amplitude than those from CTRL cells
(Figure 7C).
Figure 6 Action potential duration is longer in AF-CMs compared to CTRL-CMs. (A) Histograms of the distribution of the APD90 in AF1, AF2, and
CTRL cells, as indicated. Bin size = 40 ms. (B) Representative action potentials with the shortest (left), average (centre), and longest (right) APD90 recorded
at 1 Hz stimulation in AF1 (top), AF2 (middle), and CTRL (bottom) CMs. Dashed lines indicate the 0 mV level.
..............................................................................................................................................................................................................................
Table 1 Stimulated action potential analysis
APD30 (ms) APD50 (ms) APD90 (ms) MDP (mV) dV/dT APA (mV)
AF1 (n/exp = 40/11) 80.2 ± 9.4* 105.1 ± 11.2* 137.3 ± 12.7* -55.7 ± 1.4 57.6 ± 11.9 92.78 ± 3.9
AF2 (n/exp = 39/12) 71.2 ± 6.7* 92.6 ± 8.2 * 120.6 ± 8.8* -58.8 ± 0.9 46.6 ± 6.6 93.9 ± 3.4
CTRLs (n/exp = 61/13) 39.9 ± 3.2 52.4 ± 3.7 74.1 ± 4.1 -56.9 ± 0.9 41.3 ± 8.4 86.7 ± 2.4
Stimulated action potential properties of hiPSC-CMs paced at 1 Hz: action potential duration (APD30, 50, and 90), maximum diastolic potential (MDP), slope (dV /dT), and action
potential amplitude (APA) *P< 0.05 by one-way ANOVA.
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.4. Discussion
4.1 Whole exome screening reveals a
complex genetic background in the siblings
affected by AF
Although AF is the most prevalent cardiac arrhythmia in the developed
world,18 the pathophysiology of this complex heart rhythm disorder is
still incomplete. The changes leading to the initial occurrence of AF are
still elusive because (i) it is a progressive disease, (ii) human cardiac dis-
eased tissues have undergone extensive remodelling, and (iii) no animal
models fully recapitulate the disease.
The discovery of genetic forms of AF, linked to single gene mutations,
and genome-wide association studies have improved our knowledge of
causative mechanisms underlying AF.1 Monogenic forms of AF are rare
but, since the probability to develop AF increases in the presence of af-
fected relatives,2 a complex genetic background can be hypothesized.
Indeed, we described a family in which three siblings, diagnosed with AF,
share several mutations that can contribute to determine this
arrhythmia.
Among these genes, only ZFHX3 has been previously associated
with AF in GWAS studies.1 Nevertheless, the contribution of the
other cardiac and non-cardiac mutated genes to AF onset is hard to
dissect.
4.2 Generation of functional hiPSC-CMs
overcomes the problems linked to genetic
complexity of the disease
Because of this genetic complexity, an approach based on the evaluation
of the contribution of each single mutation is clearly unfeasible and un-
likely to provide a comprehensive description of the pathology. In order
to estimate the full range of the effects of genetic alterations, we thus
approached the problem from a functional point of view. We decided to
use patient-derived hiPSCs to obtain a human cardiac cell model that
possesses the entire patient’s genetic background. Although the limita-
tion linked to the well-known phenotypic immaturity of hiPSC-CMs,19
these cells have already been widely used to study monogenic forms of
cardiomyopathies and arrhythmias.5 On the contrary, their use for
modelling complex genetic pathologies is a rarely adopted approach.20,21
Here, we analysed for the first-time hiPSC-CMs from patients with a
complex genetic form of AF. It must be emphasized that this model does
not intend to recapitulate either the complexity of the atria or the entire
clinical aspects of the disease but represents a novel tool to understand
the molecular mechanisms underlying excitability alterations in diseased
human CMs.
Because of the lack of healthy controls within the family and the unfea-
sibility to generate isogenic hiPSCs, due to the complex genetic altera-
tions, AF clones were compared with four different lines generated from
Figure 7 AF-CMs are more arrhythmogenic. (A) Representative action potentials in Tyrode (black line) and during perfusion of 100 nM
isoproterenolþ 300 nM E4031 (red line) showing no events (top), DADs (middle), and ectopic beats (bottom) recorded from AF2-CMs paced at 0.5 Hz;
dashed lines indicate the 0 mV level. (B) Plot of the percentage of cells showing ectopic beats (AF1 7 out of 9/3 cells/exp, 78.8%*; AF2 7 out of 10/3 cells/
exp, 70.0%*; CTRL 7 out of 36/6 cell/exp, 19.5%), DADs (AF1 2 out of 9, 22.2%; AF2 2 out of 10, 20.0%; CTRL 11 out of 36, 30.5%), and no events (AF1 0
out of 9, 0%; AF2 1 out of 10, 10.0%; CTRL 18 out of 36, 50%). (C) Plot of DADs amplitude in AF1-CMs (blue triangles), AF2-CMs (green inverted triangles),
and CTRL-CMs (white circles). Values are AF1 = 6.95± 0.62* mV, n/exp = 60/3; AF2 = 6.73± 0.26* mV, n/exp = 66/3; CTRL = 5.66± 0.16 mV, n/exp = 70/6.
Percentage data were compared using Fisher’s exact test, adjusting the P-value with Bonferroni correction. Amplitude data were compared using nested
one-way ANOVA *P< 0.05.
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unrelated healthy controls. These controls were chosen based on differ-
ent variables that could potentially affect the comparison with CMs de-
rived from our patients: sex (female and male), age (middle aged), and
reprogramming procedure (retroviral infection from skin fibroblast and
keratinocyte).
Once established the pluripotency of the clones, we choose those
clones displaying a good cardiac differentiation capacity for further char-
acterization. Our molecular data on the expression of the myosin heavy
and light chain isoforms indicate that hiPSC-CMs are mainly immature/
atrial rather than ventricular cells, independently of the cell line. Because
a certain degree of maturation can be achieved in culture, especially in
the electrical properties,19 we decided to compare the AF and control
lines at an early (15–20 days) and at a late stage of differentiation (30–
35 days).
4.3 AF-CMs show a high beating rate due
to increased If and ICaL currents
We started to analyse the spontaneous beating rate of small aggregates
and found that AF-CMs beat at a significantly higher rate than those from
the controls, while no differences were found in the other parameters.
Since the beating rate is physiologically modulated by the b-adrenergic/
adenylate cyclase/cAMP pathway and an increase in rate may derive
from an imbalance of this system, we tested the ability of the cells to re-
spond to the b-adrenergic agonist isoproterenol. A saturating concen-
tration of isoproterenol caused similar increases in rate in all the lines
thus excluding differences in intracellular cAMP concentration as a cause
of the higher rate in AF-CMs. AF onset is often associated with elevated
heart rates. A few studies have indeed shown that initiation of post-
operative AF, in patients undergoing coronary artery bypass surgery,
was preceded by a significant increase in sinus rate mediated by either
high levels of circulating norepinephrine22 or by an unbalance of the au-
tonomic tone towards the sympathetic input.23
The funny current is the pacemaker current critical to the initia-
tion and regulation of cardiac pacemaker activity10 and an increase
in its contribution can indeed be arrhythmogenic.24 The expression
of f-channels (HCN1–HCN4) has been demonstrated also in non-
pacemaker cardiac cells and in the working myocardium where it is
abundant during fetal and neonatal life or under pathological con-
ditions.25 We found that the HCN4 gene is the most expressed iso-
form in hiPSC-CMs and is less expressed in AF-CMs than in
control-CMs. Direct recording of the If current from isolated
hiPSC-CMs, however, demonstrated a significant gain of function of
f-channels due to both a rightward shift of the activation curve
(both at early and late differentiation time-points) and an increase
in current density (at later stages of differentiation) in AF compared
to controls. Although molecular and functional data are discordant,
they are in agreement with previous data from Stillitano et al.26
These authors found that mRNA of HCN4 was down-regulated in
chronic atrial fibrillation (cAF) CMs while the protein level tended
to be higher. Although they have found similar current densities,
the cAF cells displayed f-channels with activation curve shifted to
more positive potentials than control cells by about 10 mV,26 simi-
lar to our results.
Since CAV3 is known to interact with HCN413 and it has been already
reported in pluripotent-derived CMs that different expression of CAV3
can shift If activation curve,
14 we analysed the CAV3 expression both at
mRNA and protein levels without detecting any difference between AF
and CTRL groups (Supplementary material online, Figure S4).
A possible contribution of an increased If current to abnormal auto-
maticity in the atrium in paroxysmal AF has been described by Nattel
and Dobrev4 in a recent review.
Our results on L-type calcium current seem to be less in accordance
with the evidence that AF induces a reduction of calcium currents.
Indeed, atrial CMs derived either from patients with AF or from animal
models of fast atrial pacing show a significant reduction of the effective
refractory period (ERP) and of the ICaL current, compared to con-
trols.4,27 The reduction of calcium current and ERP seems, however, the
consequence rather than the cause of AF and is attributable to the mal-
adaptive remodelling of atrial tissue. In support of a role of an increased
ICaL to AF, a few studies have shown that an initial calcium overload can
be the stimulus that triggers maladaptive changes in atrial protein expres-
sion, based on the evidence that the calcium blocker verapamil prevents
such remodelling.28,29
Albeit the magnitude of ICaL density has not been regularly associated
with a higher probability to develop post-cardiac surgery AF,30 it is inter-
esting to note that Van Wagoner et al.27 have shown that patients in si-
nus rhythm who developed AF following cardiac surgery had a
significantly higher pre-operative ICaL density than those that did not ex-
perience post-operative AF. This observation, together with our data
showing that CMs from AF patients display an ICaL twice as big as that of
controls, is consistent with the concept that calcium overload may be an
important factor in the initiation of AF, while ICaL depression is a conse-
quence of AF.
4.4 AF-CMs display a prolonged APD and
an increased susceptibility to arrhythmic
activity
Despite the lack of any evident modulation of specific calcium channel
isoforms, many mechanisms may contribute to an increased ICaL current
such as, for example: miRNA-mediated modulation of expression,31 al-
tered channel trafficking/recycling,32 channel oligomerization,33 and
modulation by accessory subunits.34 The observed increase of the in-
ward calcium current not accompanied by a counterbalancing increase
in outward currents is expected to prolong the APD. Indeed, Sato
et al.35 has shown that an increased cooperative gating of L-type calcium
channels increases current density and causes APD prolongation, in in sil-
ico experiments. Despite the large variability in APD duration typical of
the CMs derived from hiPSCs (Figure 6),17 we observed a significant pro-
longation of the APD in paced AF-CMs compared to controls. Usually,
variability in APD is decreased by dividing CMs in nodal-, atrial-, and
ventricular-like cell based on the slope of fast depolarization and APD
ratio.15,16 In our specific case, the selection of the cardiac cell type using
the criteria based on the APD ratio is not applicable since APD is in fact
exactly the parameter which is altered in AF-CMs, according to our
results.
Although data on calcium handling do not indicate a significant instabil-
ity of the SR, at least under ‘basal’ conditions (fixed stimulus duration and
Tyrode solution), this situation may, however, be quite different in a sce-
nario in which calcium dynamics are affected by the duration of the ac-
tion potential and/or under the prevalence of sympathetic tone. It is
known from the literature, for example, that the catecholamine-
mediated trigger for inducing AF involves a significant increase of atrial
ICaL.
36 In agreement with this situation, our data on paced cells show that
under stressful conditions (isoproterenolþ E4031) AF-CMs are signifi-
cantly more prone to generate arrhythmic events than CTRL-CMs, as in-
dicated by larger DADs that more easily give rise to ectopic beats. The
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.underlying mechanism may be related to the very long action potential
during b-adrenergic stimulation in AF-CMs in which the contribution of
ICaL become more relevant than in CTRL-CMs. Together, our data sug-
gest that the increase in ICaL and in If current are likely to be the trigger
for the initiation of AF.
4.5 Study limitations
Because sibling’s parents are deceased, and their sons/daughters are still
too young for ruling out AF, we could not derive hiPSCs from healthy
relatives. We bypassed this limitation by comparing data with those
obtained from at least three unrelated healthy controls, which displayed
similar results among them. At the time we started to collect data, no
protocols for selecting specifically atrial-like hiPSC-derived CMs were
available. However, even if we did not select a specific hiPSC-CM atrial
subpopulation, and despite the fact that the arrhythmogenesis due to a
gain of function of inward currents can be more easily demonstrated in
hiPSC-CMs lacking IK1, we believe that the changes observed in If and
ICaL could induce triggered automaticity also in vivo, specifically in the
atria, due to the fact that the adult atrium shows a significantly lower
conductance than ventricle, near the resting potential.3,37
5. Conclusions
In conclusion, we provide in the present work the first demonstration
that hiPSCs can be used as a cellular model of a human cardiac pathology
with a complex genetic background. Independently of the genetic altera-
tions, we demonstrated that hiPSC-CMs from two sisters with AF show
a higher spontaneous rate of contraction and a gain of function of both
the If and the ICaL currents relative to CMs derived from any of four con-
trol individuals. We suggest that the increase of these depolarizing cur-
rents and other still unknown factors can contribute to the induction of
abnormal automaticity in atrial cells and can thus be the triggering event
of this specific type of AF.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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Translational perspective
This is the first time a human cellular model of atrial fibrillation (AF), based on the analysis of iPSC-derived cardiomyocytes from patients, is presented.
Comparing cells from two sisters of a family with a complex genetic form of AF with those from healthy controls, we found peculiar alterations in
two ion currents potentially involved in AF aetiology. Despite progresses in the management of AF, efficacy in maintaining sinus rhythm is modest.
Human-based models elucidating the molecular mechanisms underlying AF will help define the best therapeutic approach. We propose to personal-
ize AF therapy based on functional alterations found in patient-specific cardiomyocytes.
14 P. Benzoni et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/cardiovascres/advance-article-abstract/doi/10.1093/cvr/cvz217/5555813 by guest on 15 O
ctober 2019
